Results 141 to 150 of about 184,133 (253)

From accidents to assets—The value pathways of patents for serendipitous inventions

open access: yesStrategic Management Journal, EarlyView.
Abstract Research Summary Firms often celebrate accidental inventions that lead to major breakthroughs, yet little is known about how the value of serendipitous inventions materializes. Using data from 8530 patented inventions across 23 countries, our research shows that these inventions differ from planned R&D outcomes.
Christoph Grimpe   +3 more
wiley   +1 more source

The 2022 Nobel Prize in Chemistry-sweet! [PDF]

open access: yesGlycobiology, 2023
Boyce M   +3 more
europepmc   +1 more source

Ultrasensitive MicroRNA Detection Combining Reduced Graphene Oxide Electrolyte‐Gated Transistors and Machine Learning

open access: yesSmall, EarlyView.
We developed an ultrasensitive and highly selective biosensor by integrating bio‐functionalized reduced graphene oxide (rGO) electrolyte‐gated transistors (EGTs) and machine learning (ML) to detect miRNAs (miR‐34a, miR‐34b, and miR‐34c) associated with cancer and neurological disorders.
Ana Vitória Ferreira Deleigo   +7 more
wiley   +1 more source

Why Did Treg and Immune Tolerance Win Nobel Prize This Year? [PDF]

open access: yesGenomics Proteomics Bioinformatics
Zheng 郑颂国 SG.
europepmc   +1 more source

Seeded Growth of Plasmonic Core‐Shell NU‐1000 NanoMOFs With Intracellular Optical Readout

open access: yesSmall, EarlyView.
Seed‐mediated growth yields plasmonic core‐shell nanocomposites by encapsulating gold nanoparticles within NU‐1000 nanoMOFs, preserving morphology and optical response. The materials exhibit tunable photoluminescence quenching, efficient photothermal heating, and SERS activity.
Manuel Ceballos   +9 more
wiley   +1 more source

Design, synthesis and activity evaluation of tetrahydroisoquinoline‐based programmed cell death ligand 1 inhibitors

open access: yesSmart Molecules, EarlyView.
Based on a 3D‐quantitative structure‐activity relationship pharmacophore model, structural optimization of Y6 yielded Y7f. Mechanistic studies revealed that Y7f acted as a programmed death receptor 1/programmed cell death ligand 1 (PD‐L1) interaction inhibitor by inducing PD‐L1 dimerization. Y7f restored T‐cell function.
Menglin Yu   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy